Cohance Lifesciences Limited (COHA)

Currency in INR
933.10
+0.25(+0.03%)
Closed·
COHA Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 4 days
COHA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
925.00948.25
52 wk Range
915.751,360.00
Key Statistics
Bid/Ask
924.50 / 933.10
Prev. Close
932.85
Open
942
Day's Range
925-948.25
52 wk Range
915.75-1,360
Volume
68.14K
Average Volume (3m)
248.71K
1-Year Change
-6%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COHA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,304.67
Upside
+39.82%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Cohance Lifesciences Limited Company Profile

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.

Employees
1193
Market
India

Compare COHA to Peers and Sector

Metrics to compare
COHA
Peers
Sector
Relationship
P/E Ratio
133.3x45.5x−0.5x
PEG Ratio
−11.680.210.00
Price/Book
21.0x3.9x2.6x
Price / LTM Sales
29.8x5.6x3.3x
Upside (Analyst Target)
37.1%14.2%43.5%
Fair Value Upside
Unlock−4.7%6.8%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,304.67
(+39.82% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
3.50 / --
Revenue / Forecast
8.41B / --
EPS Revisions
Last 90 days

COHA Income Statement

People Also Watch

5,815.50
KAYN
-4.49%
1,073.00
KFIN
-1.53%
1,291.50
UNSP
+0.12%
384.60
BAJE
-0.81%
1,245.30
MAXE
-1.63%

FAQ

What Stock Exchange Does Cohance Lifesciences Trade On?

Cohance Lifesciences is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Cohance Lifesciences?

The stock symbol for Cohance Lifesciences is "COHA."

What Is the Cohance Lifesciences Market Cap?

As of today, Cohance Lifesciences market cap is 356.97B.

What Is Cohance Lifesciences's Earnings Per Share (TTM)?

The Cohance Lifesciences EPS (TTM) is 10.52.

When Is the Next Cohance Lifesciences Earnings Date?

Cohance Lifesciences will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is COHA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cohance Lifesciences Stock Split?

Cohance Lifesciences has split 1 times.

How Many Employees Does Cohance Lifesciences Have?

Cohance Lifesciences has 1193 employees.

What is the current trading status of Cohance Lifesciences (COHA)?

As of 09 Aug 2025, Cohance Lifesciences (COHA) is trading at a price of 933.10, with a previous close of 932.85. The stock has fluctuated within a day range of 925.00 to 948.25, while its 52-week range spans from 915.75 to 1,360.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.